Circulating microRNAs in Neurodegenerative Diseases

Area of Science:

• Neuroscience
• Biomarker Discovery
• Molecular Biology

Background:

• Neurodegenerative diseases (Alzheimer's, Parkinson's, ALS) share overlapping clinical, pathological, and genetic features.
• Early events like synaptic dysfunction precede neuronal loss, complicating diagnosis due to brain compensation.
• Current diagnostic methods often detect disease late, limiting treatment efficacy.

Purpose of the Study:

• To explore the potential of microRNAs (miRNAs) as early diagnostic biomarkers for neurodegenerative diseases.
• To investigate miRNAs as a minimally invasive tool for screening and identifying therapeutic targets.

Main Methods:

• Review of current literature on neurodegenerative disease biomarkers.
• Analysis of microRNA characteristics (stability, specificity, cost-effectiveness).

Main Results:

• MicroRNAs are stable, tissue-specific, and cost-effective biomarkers.
• MiRNAs can be detected in human body fluids, enabling minimally invasive testing.
• They represent a promising tool for early detection of neurodegenerative conditions.

Conclusions:

• MicroRNAs hold significant potential as diagnostic signatures for neurodegenerative disorders.
• Utilizing miRNAs could lead to the development of early screening tests and novel therapeutic strategies.